341 related articles for article (PubMed ID: 30832219)
1. Cancer-Associated Fibroblasts' Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Awaji M; Singh RK
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832219
[TBL] [Abstract][Full Text] [Related]
2. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
Shinkawa T; Ohuchida K; Nakamura M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
[TBL] [Abstract][Full Text] [Related]
4. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
Ijichi H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
[TBL] [Abstract][Full Text] [Related]
5. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer.
Morgan A; Griffin M; Kameni L; Wan DC; Longaker MT; Norton JA
Biology (Basel); 2023 Jul; 12(8):. PubMed ID: 37626931
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment.
Norton J; Foster D; Chinta M; Titan A; Longaker M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32466266
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis.
Barrera LN; Ridley PM; Bermejo-Rodriguez C; Costello E; Perez-Mancera PA
J Physiol Biochem; 2023 Feb; 79(1):193-204. PubMed ID: 35767180
[TBL] [Abstract][Full Text] [Related]
8. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.
Sun Q; Zhang B; Hu Q; Qin Y; Xu W; Liu W; Yu X; Xu J
Theranostics; 2018; 8(18):5072-5087. PubMed ID: 30429887
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer.
Geng X; Chen H; Zhao L; Hu J; Yang W; Li G; Cheng C; Zhao Z; Zhang T; Li L; Sun B
Front Cell Dev Biol; 2021; 9():655152. PubMed ID: 34336821
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
12. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.
Cannon A; Thompson C; Hall BR; Jain M; Kumar S; Batra SK
Genes Cancer; 2018 Mar; 9(3-4):78-86. PubMed ID: 30108679
[TBL] [Abstract][Full Text] [Related]
13. The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.
Bolm L; Cigolla S; Wittel UA; Hopt UT; Keck T; Rades D; Bronsert P; Wellner UF
Transl Oncol; 2017 Aug; 10(4):578-588. PubMed ID: 28658650
[TBL] [Abstract][Full Text] [Related]
14. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
15. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma.
Lee DU; Han BS; Jung KH; Hong SS
Biomol Ther (Seoul); 2024 May; 32(3):281-290. PubMed ID: 38590092
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8.
Awaji M; Futakuchi M; Heavican T; Iqbal J; Singh RK
Cancer Microenviron; 2019 Apr; 12(1):37-46. PubMed ID: 31025289
[TBL] [Abstract][Full Text] [Related]
17. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
19. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines.
Gorchs L; Kaipe H
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203869
[TBL] [Abstract][Full Text] [Related]
20. Desmoplasia in Lymph Node Metastasis of Pancreatic Adenocarcinoma Reveals Activation of Cancer-Associated Fibroblasts Pattern and T-helper 2 Immune Cell Infiltration.
Nizri E; Bar-David S; Aizic A; Sternbach N; Lahat G; Wolf I; Klausner J
Pancreas; 2019 Mar; 48(3):367-373. PubMed ID: 30768574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
